HealthCare Global Enterprises Ltd (HCG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:HealthCare Global Enterprises Ltd (HCG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013307
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that offers medical care and treatment services. The company offers services such as clinical laboratory services, diagnosis services, medical oncology services, radiation oncology services and surgical oncology services, among others. It provides other services such as integrated molecular pathology services, accurate diagnosis treatment services, 3 TMRI services, ABVS services, digital mammogram services, PET CT scanning services, and accurate pathological diagnosis services. HCG offers medical oncology services such as haemato oncology, paediatric oncology, breast health centre, preventive oncology, day care chemotherapy, patient counseling, and integrative oncology services. The company provides radiation oncology services such as brachytherapy, cyberknife robotic surgery and hyperthermia services, among others. It operates through a network of hospitals across India. HCG is headquartered in Bangalore, Karnataka, India.

HealthCare Global Enterprises Ltd (HCG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Temasek Invests US$27 Million In HealthCare Global Enterprises 10
IDFC PE Sells Its Stake In HealthCare Global To PremjiInvest And Milestone Capital 11
Partnerships 12
HealthCare Global Enterprises Forms Joint Venture With Medica Synergie 12
Merger 13
HealthCare Global Enterprises Plans To Merge With Medica Synergie 13
Equity Offering 14
HealthCare Global Prices USD5.4 Million in Private Placement of Shares 14
Healthcare Global Enterprises Plans to Raise Funds through Rights Offering of Shares 15
HealthCare Global Enterprises Files Registration Statement for IPO for up to USD102 Million 16
Acquisition 17
HealthCare Global Acquires Majority Stake In Bangalore Assisted Conception Centre 17
HealthCare Global Enterprises Ltd – Key Competitors 18
HealthCare Global Enterprises Ltd – Key Employees 19
HealthCare Global Enterprises Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
HealthCare Global Enterprises Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
HealthCare Global Enterprises Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Temasek Invests US$27 Million In HealthCare Global Enterprises 10
IDFC PE Sells Its Stake In HealthCare Global To PremjiInvest And Milestone Capital 11
HealthCare Global Enterprises Forms Joint Venture With Medica Synergie 12
HealthCare Global Enterprises Plans To Merge With Medica Synergie 13
HealthCare Global Prices USD5.4 Million in Private Placement of Shares 14
Healthcare Global Enterprises Plans to Raise Funds through Rights Offering of Shares 15
HealthCare Global Enterprises Files Registration Statement for IPO for up to USD102 Million 16
HealthCare Global Acquires Majority Stake In Bangalore Assisted Conception Centre 17
HealthCare Global Enterprises Ltd, Key Competitors 18
HealthCare Global Enterprises Ltd, Key Employees 19
HealthCare Global Enterprises Ltd, Other Locations 20

★海外企業調査レポート[HealthCare Global Enterprises Ltd (HCG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Providence Resources plc (PZQA):企業の財務・戦略的SWOT分析
    Summary Providence Resources Plc (Providence Resource) is an upstream oil and gas exploration and development company that explores and develops hydrocarbon assets. The company's areas of operations include Northern Porcupine basin, Southern Porcupine basin, Goban Spur basin, Saint George's basin an …
  • Alchemia Ltd (ACL)-製薬・医療分野:企業M&A・提携分析
    Summary Alchemia Ltd (Alchemia) is a biopharmaceutical company that focuses on the discovery and development of drugs for the treatment of cancer and respiratory disorders. It sold the worldwide exclusive intellectual property rights to its product, Fondaparinux sodium (a generic version of the anti …
  • Community Trust Bancorp Inc:企業の戦略・SWOT・財務情報
    Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report Summary Community Trust Bancorp Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Impellam Group plc (IPEL):企業の財務・戦略的SWOT分析
    Impellam Group plc (IPEL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Duro Dakovic Group Plc:企業の戦略・SWOT・財務情報
    Duro Dakovic Group Plc - Strategy, SWOT and Corporate Finance Report Summary Duro Dakovic Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Nice-Pak Products, Inc.:企業の戦略・SWOT・財務情報
    Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nice-Pak Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • OBJ Ltd (OBJ)-医療機器分野:企業M&A・提携分析
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • Twilio Inc (TWLO):企業の財務・戦略的SWOT分析
    Twilio Inc (TWLO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Karyopharm Therapeutics Inc (KPTI):企業の財務・戦略的SWOT分析
    Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Meggitt Training Systems, Inc.:企業の戦略・SWOT・財務情報
    Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • NCR Corporation:企業のM&A・事業提携・投資動向
    NCR Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NCR Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Arena Energy LP:石油・ガス:M&Aディール及び事業提携情報
    Summary Arena Energy Lp (Arena) operates as an oil and gas exploration company. It is engaged in developing and exploring of oil and gas in Gulf of Mexico. It identifies and develops investment opportunities in the Gulf of Mexico Shelf. It is also involved in drilling and off-shore activities. The c …
  • Tomra Systems ASA (TOM):企業の財務・戦略的SWOT分析
    Summary Tomra Systems ASA (Tomra Systems) is a logistics company that offers collection and sorting solutions. The company offers products such as managing tools, process analytics equipment, food processing lines, sorting systems, raw materials, raw material sorting equipment, and other specialty p …
  • Tivo Corporation:戦略・SWOT・企業財務分析
    Tivo Corporation - Strategy, SWOT and Corporate Finance Report Summary Tivo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • JEOL Ltd (6951):企業の財務・戦略的SWOT分析
    JEOL Ltd (6951) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析
    West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Ashghal:企業の戦略・SWOT・財務情報
    Ashghal - Strategy, SWOT and Corporate Finance Report Summary Ashghal - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Compania Espanola de Petroleos SAU:企業の戦略・SWOT・財務分析
    Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report Summary Compania Espanola de Petroleos SAU - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Thermal Energy International Inc (TMG):企業の財務・戦略的SWOT分析
    Summary Thermal Energy International Inc (Thermal Energy) is a cleantech company. The company supplies proprietary energy efficiency and emission reduction solutions to industrial and institutional sectors. Its products include GEM steam traps, FLU-ACE heat recovery systems, Dry Rex biomass dryer, a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆